CD44v6-containing isoforms are frequently de novo expressed in gastric cancer (GC). Whether CD44v6 has a central role in GC transformation and/or progression, whether it conditions response to therapy or whether it is only a bystander marker is still not known. Therefore, we aimed to clarify the role of CD44v6 in GC. We generated GC isogenic cell lines stably expressing CD44s or CD44v6 and tested them for different cancer hallmarks and response to cisplatin, and we further confirmed our findings in cells that endogenously express CD44v6. No correlation between overexpression of CD44v6 and the tested cancer hallmarks was observed, suggesting CD44v6 is not a driver of GC progression. Upon cisplatin treatment, CD44v6+ cells survive better and ...
Members of the CD44 family of transmembrane glycoproteins emerge as major signal transduction contro...
De novo expressed CD44 isoforms containing exon-v6 are frequently associated with gastric cancer (GC...
Prostate cancer (CaP) is the second leading malignancy in older men in Western countries. The role o...
CD44v6-containing isoforms are frequently de novo expressed in gastric cancer (GC). Whether CD44v6 h...
As a cancer stem cell marker, CD44 variant 6 (CD44v6) has been implicated in carcinogenesis, tumor p...
Background/Aims: The prognostic power of the levels of total CD44 and its isoform CD44v6 for patient...
De novo expressed CD44 isoforms containing exon-v6 are frequently associated with gastric cancer (GC...
In gastric cancer (GC), biomarkers that define prognosis and predict treatment response remain scarc...
Expression of CD44 variants in some tissues appears to relate to tumor progression, and particularly...
Expression of CD44 variants in some tissues appears to relate to tumor progression, and particularly...
Expression of CD44 variants in some tissues appears to relate to tumor progression, and particularly...
Gastric cancer is the third most common cause of cancer-related death. Although the incidence of gas...
International audienceBackground: Cancer stem cells (CSCs) are at the origin of tumour initiation an...
Gastric cancer remains a public health concern all over the world and specifically in South America ...
Abstract Background Cisplatin is the most commonly used chemotherapeutic agent in the treatment of p...
Members of the CD44 family of transmembrane glycoproteins emerge as major signal transduction contro...
De novo expressed CD44 isoforms containing exon-v6 are frequently associated with gastric cancer (GC...
Prostate cancer (CaP) is the second leading malignancy in older men in Western countries. The role o...
CD44v6-containing isoforms are frequently de novo expressed in gastric cancer (GC). Whether CD44v6 h...
As a cancer stem cell marker, CD44 variant 6 (CD44v6) has been implicated in carcinogenesis, tumor p...
Background/Aims: The prognostic power of the levels of total CD44 and its isoform CD44v6 for patient...
De novo expressed CD44 isoforms containing exon-v6 are frequently associated with gastric cancer (GC...
In gastric cancer (GC), biomarkers that define prognosis and predict treatment response remain scarc...
Expression of CD44 variants in some tissues appears to relate to tumor progression, and particularly...
Expression of CD44 variants in some tissues appears to relate to tumor progression, and particularly...
Expression of CD44 variants in some tissues appears to relate to tumor progression, and particularly...
Gastric cancer is the third most common cause of cancer-related death. Although the incidence of gas...
International audienceBackground: Cancer stem cells (CSCs) are at the origin of tumour initiation an...
Gastric cancer remains a public health concern all over the world and specifically in South America ...
Abstract Background Cisplatin is the most commonly used chemotherapeutic agent in the treatment of p...
Members of the CD44 family of transmembrane glycoproteins emerge as major signal transduction contro...
De novo expressed CD44 isoforms containing exon-v6 are frequently associated with gastric cancer (GC...
Prostate cancer (CaP) is the second leading malignancy in older men in Western countries. The role o...